Status:

ACTIVE_NOT_RECRUITING

Neuromuscular Inhibition Technique on Iliotibial Band Friction Syndrome

Lead Sponsor:

Cairo University

Conditions:

Iliotibial Band Syndrome

Eligibility:

All Genders

30-50 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to find the effect of integrated neuromuscular inhibition technique for iliotibial band in iliotibial band friction syndrome on pain intensity level, pressure pain t...

Eligibility Criteria

Inclusion

  • Body mass index from 25-30 kg/m2
  • Both males and females will be included their age from 30-50.
  • The subjects that will be included in the study will be referred from orthopeadic physician with iliotibial band friction syndrome with these signs and symptoms
  • local tenderness of the lateral knee inferior to the epicondyle and superior to the joint line
  • Pain with ITBS can be reported anywhere along the iliotibial (IT) band from the lateral thigh to the lateral femoral condyle and Gerdy's tubercle.
  • Pain is most intense at approximately 30 degrees of knee.
  • A sharp, burning pain when the practitioner presses on the lateral epicondyle during knee flexion and extension associated with one of these cases:
  • Tibiofermoral knee pain.
  • Patellofemoral knee pain.
  • osteoarthritis with medial knee joint pain
  • Lateral patellar pressure syndrome.
  • Medial meniscus degeneration.
  • Excessive lateral pressure syndrome

Exclusion

  • Traumatic injury to the knee joint within 6 months.
  • Surgical procedure on the affected knee within the last 12 months.
  • Meniscus injury
  • knee ligaments injury
  • Malignancies, tumors or infections associated with the knee joint.
  • Impaired thermal sensation over the knee.
  • Subject with psychiatric disorder.
  • Peripheral vascular disease.
  • Severe joint deformity.
  • Current back or ankle pain.
  • Rheumatoid arthritis.
  • Lower extremity fracture.
  • Neurological defecit or movement disorder.
  • Athletes.
  • Menopause
  • Pregnancy
  • Auto immune disease
  • Chronic disease (Diabetes mellitus and Hypertension)

Key Trial Info

Start Date :

March 2 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06980324

Start Date

March 2 2024

End Date

July 1 2025

Last Update

May 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of physical therapy, Cairo university

Giza, Egypt